Authors:
Hall, PD
Virella, G
Willoughby, T
Atchley, DH
Kreitman, RJ
Frankel, AE
Citation: Pd. Hall et al., Antibody response to DT-GM, a novel fusion toxin consisting of a truncateddiphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia, CLIN IMMUNO, 100(2), 2001, pp. 191-197
Citation: Rl. Alexander et al., High affinity interleukin-3 receptor expression on blasts from patients with acute myelogenous leukemia correlates with cytotoxicity of a diphtheria toxin/IL-3 fusion protein, LEUK RES, 25(10), 2001, pp. 875-881
Authors:
Senchenkov, A
Han, TY
Wang, HT
Frankel, AE
Kottke, TJ
Kaufmann, SH
Cabot, MC
Citation: A. Senchenkov et al., Enhanced ceramide generation and induction of apoptosis in human leukemia cells exposed to DT388-granulocyte-macrophage colony-stimulating factor (GM-CSF), a truncated diphtheria toxin fused to human GM-CSF, BLOOD, 98(6), 2001, pp. 1927-1934
Authors:
Lilly, MB
Zemskova, M
Frankel, AE
Salo, J
Kraft, AS
Citation: Mb. Lilly et al., Distinct domains of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit mediate activation of Jak/Stat signaling and differentiation, BLOOD, 97(6), 2001, pp. 1662-1670
Authors:
Alexander, RL
Kucera, GL
Klein, B
Frankel, AE
Citation: Rl. Alexander et al., In vitro interleukin-3 binding to leukemia cells predicts cytotoxicity of a diphtheria toxin/IL-3 fusion protein, BIOCONJ CHE, 11(4), 2000, pp. 564-568
Authors:
Frankel, AE
McCubrey, JA
Miller, MS
Delatte, S
Ramage, J
Kiser, M
Kucera, GL
Alexander, RL
Beran, M
Tagge, EP
Kreitman, RJ
Hogge, DE
Citation: Ae. Frankel et al., Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias, LEUKEMIA, 14(4), 2000, pp. 576-585
Authors:
Frankel, AE
Ramage, J
Kiser, M
Alexander, R
Kucera, G
Miller, MS
Citation: Ae. Frankel et al., Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor, PROTEIN ENG, 13(8), 2000, pp. 575-581
Authors:
Frankel, AE
Ramage, J
Latimer, A
Feely, T
Delatte, S
Hall, P
Tagge, E
Kreitman, R
Willingham, M
Citation: Ae. Frankel et al., High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials, PROT EX PUR, 16(1), 1999, pp. 190-201
Authors:
Hall, PD
Willingham, MC
Kreitman, RJ
Frankel, AE
Citation: Pd. Hall et al., DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte-macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemia, LEUKEMIA, 13(4), 1999, pp. 629-633
Authors:
Kim, CN
Bhalla, K
Kreitman, RJ
Willingham, MC
Hall, P
Tagge, EP
Jia, T
Frankel, AE
Citation: Cn. Kim et al., Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factorand Ara-C exert synergistic toxicity against human AML HL-60 cells, LEUK RES, 23(6), 1999, pp. 527-538
Authors:
Hotchkiss, CE
Hall, PD
Cline, JM
Willingham, MC
Kreitman, RJ
Gardin, J
Latimer, A
Ramage, J
Feely, T
DeLatte, S
Tagge, EP
Frankel, AE
Citation: Ce. Hotchkiss et al., Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor, in cynomolgus monkeys, TOX APPL PH, 158(2), 1999, pp. 152-160